Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-25

Clinical Trial Update: Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects [EARLY_Phase 1]

View source ↗

Summary

Phase 1 exploratory study of flortaucipir injection in healthy volunteers and cognitively impaired subjects with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flortaucipir (flortaucipir)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer Disease | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2020-09-25